Sample News Articles
Saluda’s IPO on ASX Points Up Vulnerability of SCS Market
The muted response to the public offering is another disappointing valuations for SCS firms. [Dec25]
NBR Editors Interview BCI Researchers at Neuroscience 2025
Jeremy Koff and James Cavuoto quizzed three prominent BCI investigaors during a press conference at the Neuroscience 2025 meeting. [Nov25]
Australian TGA Issues Hazard Alert for Several Medtronic Stimulators
Several models of DBS and SCS systems are prone to ove- or under-stimulation. [Feb14]
Neurotech Reports Announces Winners of Gold Electrode Awards
The awards were presented at the 2013 Neurotech Leaders Forum in San Francisco. [Oct13]
EnteroMedics CEO Offers Explanation of Failed Obesity Trial

Mark Knudson noted that both treatment and control groups achieved 23 percent excess weight loss after 12 months using the implanted Maestro device. [Jan10]